Researchers at NYU Langone Medical Center have investigated a novel protein test to detect early-stage, asbestos-related pulmonary cancer. The test can accurately identify proteins secreted from cancerous tumors caused by asbestos exposure. The study was presented at the American Association for Cancer Research 102nd Annual Meeting 2011 on April 4th.
NYU Langone is the first in the world to utilize a new near-infrared fluorescence imaging guidance system for selective arterial clamping during kidney sparing surgery for patients with kidney cancer and is among small select group of hospitals in the country and the only one in the northeast to have this technology.
Daniel F. Roses, MD, the Jules Leonard Whitehill Professor of Surgery and Oncology and chief of the Division of Surgical Oncology at NYU Langone Medical Center was awarded the Tower of Hope Dr. Daniel G. Miller Excellence in Medicine Award by the Israel Cancer Research Fund (ICRF) this month.
NYU Langone Medical Center’s John P. Curtin, MD, professor and director of the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology has been elected the 43rd President of the Society of Gynecologic Oncologists (SGO). Dr. Curtin was elected at its 42nd Annual Meeting, held in March 2011.
Chandranath Sen, Noel Perin and Howard Riina add breadth, depth and expertise in skull base surgery, brain tumors, disorders of the spine, cerebrovascular neurosurgery, interventional neuroradiology and stroke.
Researchers from across multiple disciplines at NYU Langone Medical Center created a new protein molecule derived from the growth factor progranulin may provide the basis for new therapies in inflammatory diseases, such as rheumatoid arthritis, according to a study published in the March 10, 2011 issue of Science.
A new study conducted by researchers at NYU Langone Medical Center and Yale School of Medicine shows that when hospitals acquire surgical robotic technology, men in that region are more likely to have prostate cancer surgery. The study, “The Association between Diffusion of the Surgical Robot and Radical Prostatectomy Rates”, was published this week in the online edition of the journal Medical Care.
Scientists discover a genetic variant that allows a fish in the Hudson River to live in waters heavily polluted by PCBs.
NYU Langone one of only 16 U.S. locations selected, patient data will improve technology and long-term outcomes of joint replacement surgery.
A new study led by an NYU School of Medicine investigator and published in the February 15, 2011, Advance Online Publication, International Journal of Obesity, challenges the idea that calorie labeling has an effect on the purchasing behavior of teenagers or what parents purchase for their children.
NYU Langone Medical Center is pleased to announce that it was recently designated an official Baby-Friendly™ Hospital. It is the only academic medical center in New York City to receive this designation and the second hospital in New York City. The Baby-Friendly™ designation has only been awarded to 105 hospitals and birth centers nationally.
NYU School of Medicine will host its 6th Annual Conference on the Health of the African Diaspora entitled New York City African Community Based Organizations (CBO) Forum: Transformation through Collaboration on February 19, 2011.
NYU Langone Medical Center is pleased to announce the opening of The Rita J. and Stanley H. Kaplan Stem Cell/Bone Marrow Transplant Center (Kaplan Center), dedicated to providing stem cell transplants and comprehensive in-patient and out-patient care for adult and pediatric patients with hematologic cancers. The Center was established with a generous $ 4.2M gift from the Rita J. Kaplan and Stanley H. Kaplan Family Foundation.
NYU Langone Medical Center today announced its plan to transform its Emergency Department (ED) into a state-of the-art emergency facility to meet the growing need for emergency care services in the community. Once completed, the new facility will nearly triple the size of the current ED and will include for the first time a separate area dedicated to pediatric emergency services.
NYU Langone Medical Center announced today it received a $21 million gift from Remicade co-inventor Jan T. Vilcek, MD, PhD, professor, Department of Microbiology, and his wife, Marica F. Vilcek, in support of research and education at the Medical Center.
Parent education programs delivered through pediatric primary care offices increased parent-child play and reading activities critical for child development and school readiness during infancy in at-risk families, according to two concurrent reports in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
NYU Langone Medical Center announced today that it has appointed internationally renowned scientist and leader Richard W. Tsien, DPhil, as the first director of the Neuroscience Institute and the Druckenmiller Professor of Neuroscience, effective January 2012.
A school-based intervention program helped New York City high school students with moderate to severe asthma better manage their symptoms, dramatically reducing the need for urgent care, including hospitalizations and emergency room visits, according to a study published online in the American Journal of Respiratory and Critical Care Medicine.
Researchers from The Cancer Institute at NYU Langone Medical Center will present at the 52nd Annual American Society of Hematology (ASH) Meeting and Exposition on December 4-7, 2010 in Orlando, Florida. They will be available for interviews during the conference about the following abstract presentations:
An international team has identified a gene that appears to be an important switch in determining whether the biological program for the development of gender will go according to plan, or if, when mutated, will cause a glitch in the program.
A new study involving a man who swallowed worm eggs to relieve symptoms of ulcerative colitis sheds light on how worms promote healing in the intestine.
Mayor Michael R. Bloomberg and the New York Organ Donation Network today announced the launch of a new pilot program to honor the wishes of registered organ donors and help save lives. Nearly 8,000 people in New York City are waiting for a life-saving organ transplant, yet the United States does not have a procedure in place to recover organs from locations outside of hospitals. The new pilot program, made possible by a partnership between Bellevue Hospital and the City’s Police and Fire Departments, will allow the City to test the feasibility of recovering organs from the 400-plus eligible people who die of cardiac arrest outside of Manhattan City hospitals each year.
Instructions on boxes and bottles of over-the-counter (OTC) medicines for children in the United States are confusing and hard for parents to understand and follow, according to a study in the December 1 issue of JAMA.
As part of its ongoing commitment to providing patient-centered care, NYU Langone Medical Center has created a state-of-the-art pharmacy to maximize efficiency and enhance patient safety. Made possible as part of a generous gift from the Tisch families, the new pharmacy features advanced robotic equipment that automatically sorts and dispenses medications with 99.99% accuracy. Located on the 3rd floor of the Medical Center’s flagship Tisch Hospital, the new pharmacy is the first of its kind in New York City and the second in New York State.
Scientists studying genetic data from nearly 50,000 people have uncovered several DNA sequence variations associated with the electrical impulses that make the heart beat. The findings, reported in Nature Genetics, may pave the way for a greater understanding of the mechanisms for abnormal heart rhythms and sudden cardiac death.
NYU Langone Medical Center is pleased to announce that it has established The Smilow Comprehensive Prostate Cancer Center with a $5 million gift from Joel E. Smilow, a member of the Board of Trustees at NYU Langone Medical Center and New York University. The Smilow Center is dedicated to providing comprehensive, state-of-the-art personalized care for men with prostate cancer as well as educating men and their families about the disease and the wide range of treatment options available today.
NYU Langone Medical Center endocrinologists can comment on all aspects of diagnosing and treating diabetes.
The National Institutes of Health (NIH) announced today that Martin J. Blaser, MD, the Frederick H. King Professor of Internal Medicine at NYU Langone Medical Center has been awarded one of only twenty NIH Director’s Transformative Research Projects (T-R01) award for research entitled “Disappearing Gastrointestinal Microbiota in Epidemic Obesity. The project will examine whether changes in the human microbiome as a result of antibiotic use early in life has fueled the epidemic of obesity. The amount of the award is approximately $6.6 million over a five year period.
The Center of Excellence (COE) on Brain Aging at NYU Langone Medical Center has established a specialty center for the diagnosis and treatment of Lewy Body Disease, a multi-system disease involving disturbances of cognition, behavior, sleep and autonomic function.
Researchers from the Cardiac & Vascular Institute at NYU Langone Medical Center will present at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 scientific symposium on September 21-25, 2010 in Washington, DC. They will be available for interviews during the conference.
September is Prostate Cancer Awareness Month. Each year over 32,000 men will die from prostate cancer and about 1 in 6 men will be diagnosed during their lifetime with the disease -- the second most common type of cancer in men. Prostate cancer specialists from the Smilow Comprehensive Prostate Cancer Center at NYU Langone Medical Center are lead investigators for clinical trials using the latest minimally invasive treatments for prostate cancer including: high-intensity focused ultrasound (HIFU) that uses high-energy sound waves to destroy cancer cells without radiation and vascular-targeted photodynamic therapy (PDT) that destroys cancer using light energy waves.
According to a new study a protein crucial for the immune response appears to be a key player in the progression of a devastating form of childhood leukemia called T-cell acute lymphoblastic leukemia (T-ALL). Suppressing the activity of the protein kills the leukemic cells, the study shows, opening a potential avenue to new drugs that could prevent progression of the disease.
Dendritic cells are the grand sentinels of the immune system, standing guard 24/7 to detect foreign invaders such as viruses and bacteria, and bring news of the invasion to other immune cells to marshal an attack. These sentinels, however, nearly always fail to respond adequately to HIV, the virus causing AIDS. Now a team of scientists at NYU Langone Medical Center has discovered a sensor in dendritic cells that recognizes HIV, spurring a more potent immune response by the sentinels to the virus. They report their findings in the September 9, 2010, issue of Nature.
In a surprising and unexpected discovery, scientists at NYU Langone Medical Center have found that a single type of gene acts as a master organizer of motor neurons in the spinal cord. The finding, published in the September 9, 2010 issue of Neuron, could help scientists develop new treatments for diseases such as Lou Gehrig’s disease or spinal cord injury.
Scientists have sequenced the entire genome of an ant, actually two very different species of ant, and the insights gleaned are already yielding tantalizing clues to the extraordinary social behavior of ants.
A White Coat Ceremony for the Class of 2014 will be held on Friday, August 20, at 1PM at the NYU School of Medicine. The White Coat Ceremony signifies the end of Orientation for new medical students and the beginning of their career as a medical student. This ceremony creates a psychological, intellectual, and ethical contract for the profession and promotes empathy in the practice of medicine from the very start of medical training.
The Urothelial Biology Team at NYU School of Medicine received an $8.2 million, five-year program project (P01) grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health to continue groundbreaking research on bladder biology and diseases including urinary tract infection (UTI).
A study by researchers at NYU Langone Medical Center have found that obese adolescents with type 2 diabetes have diminished cognitive performance and subtle abnormalities in the brain as detected by Magnetic Resonance Imaging (MRI). Identification of cognitive impairments as a complication of type 2 diabetes emphasizes the importance of addressing issues of inactivity and obesity, two important risk factors for the development of the disease among the young. The study appeared online in the journal Diabetologia, July 30, 2010.
The NYU Health Promotion and Prevention Research Center (NYU PRC) at the NYU School of Medicine announced it has received a $3.2 million award from the Centers for Disease Control and Prevention (CDC) to establish a Comparative Effectiveness Research Program focused on hypertension and colorectal cancer health disparities in African-American men in New York City.
NYU Langone Medical Center has begun a clinical trial offering vascular-targeted photodynamic therapy to patients with localized prostate cancer. This novel, minimally invasive procedure uses a light-activated drug to deliver light energy waves by way of laser fibers in order to destroy prostate cancer cells.
NYU Langone Medical Center Physicians are available to discuss Back to School Issues for parents and teachers.
Press release announcing that Moses Chao, PhD, professor of cell biology, physiology and neuroscience, and psychiatry at NYU School of Medicine, and a member of the Molecular Neurobiology Program at the Skirball Institute of Biomolecular Medicine, was named president-elect of the Society for Neuroscience (SfN).
A new study by researchers at NYU School of Medicine found that UVA radiation damages the DNA in human melanocyte cells, causing mutations that can lead to melanoma. Melanocytes, which contain a substance called melanin that darkens the skin to protect it from the ultraviolet rays of the sun, are more vulnerable to UVA radiation than normal skin cells because they are unable to repair themselves as efficiently.
NYU Langone Medical Center has received a $5.4 million shared facility award from the Empire State Stem Cell Board’s New York State Stem Cell Science (NYSTEM) program.
New research from NYU Langone Medical Center shows that a simple, inexpensive and noninvasive carotid artery ultrasound of the neck can be used as a preliminary diagnostic tool for coronary artery disease (CAD). This may be an alternative to the standard, expensive and more invasive coronary angiography. The ultrasound test can also be used to rule out the diagnosis of CAD in patients presenting with reduced heart pump function.
Researchers have discovered how mutations in the presenilin 1 gene cause early-onset Alzheimer’s disease (AD). The finding, reported online in the journal Cell, opens the door to developing novel treatments for this form of the mind-robbing disease and for the more common, late-onset form that develops later in life and affects millions of people worldwide.
Through the use of sophisticated genomic analysis, researchers at NYU Langone Medical Center have found that the genetic influences of the Jewish people have retained their genetic coherence, as well as their cultural and religious traditions, even as Jewish communities migrated from the Middle East into Europe, North Africa and across the world according to a new study in the American Journal of Human Genetics.
Experts from The Cancer Institute at NYU Langone Medical Center will present new research findings at the 46th Annual Meeting of The American Society of Clinical Oncology (ASCO) in Chicago, Illinois. The conference will run from June 4-8, 2010 and scientists from the NYU Cancer Institute will be available to discuss various topics including improved ways to diagnose melanoma in lymphatic vessels, genetic differences in melanoma subtypes and post-transplant lymphoproliferative disorders that are a potential serious complication after organ or bone marrow transplant.
New York University School of Medicine will hold its 168th annual graduation ceremony on May 13, 2010, at 10 a.m. at Avery Fisher Hall at Lincoln Center in Manhattan. Maria Bartiromo, host of CNBC's “Closing Bell,” host and managing editor of the nationally syndicated “Wall Street Journal Report with Maria Bartiromo” an alumna and trustee of New York University will address the class of 2010 .
A new study from researchers at NYU Langone Medical Center found that the imprint of European colonialism and imperialism is evident in the genetic makeup of today’s Hispanic/Latino American populations. Scientists discovered that Europeans, Native Americans, as well as West Africans brought to the U.S. and Latin America by the trans-Atlantic slave trade, have influenced the genes of the current Hispanic/Latino populations. However, a large variation in genes among individuals within each population were still found to exist.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right